{"id":354066,"date":"2025-08-28T10:36:46","date_gmt":"2025-08-28T10:36:46","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-repligen-corporation\/"},"modified":"2025-08-28T10:36:46","modified_gmt":"2025-08-28T10:36:46","slug":"how-to-buy-repligen-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/","title":{"rendered":"Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Repligen Corporation (RGEN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-354066","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Repligen Corporation (RGEN) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Repligen Corporation (RGEN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Repligen Corporation (RGEN) hisselerine yat\u0131r\u0131m yapmay\u0131 \u00f6\u011frenin; g\u00fcncel fiyat $118.88, analist tahminleri ve biyoprocessing sekt\u00f6r lideri i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci.","description_source":{"label":"Description","type":"textarea","formatted_value":"Repligen Corporation (RGEN) hisselerine yat\u0131r\u0131m yapmay\u0131 \u00f6\u011frenin; g\u00fcncel fiyat $118.88, analist tahminleri ve biyoprocessing sekt\u00f6r lideri i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci."},"intro":"B\u00fcy\u00fcyen biyoprocessing devriminden faydalanmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Repligen Corporation, ya\u015fam bilimleri inovasyonunun \u00f6n saflar\u0131nda yer alarak, yeni nesil tedavilerin geli\u015ftirilmesini destekliyor. K\u00fcresel biyoprocessing pazar\u0131 2030 y\u0131l\u0131na kadar 25 milyar dolardan 50 milyar dolar\u0131n \u00fczerine \u00e7\u0131karken, Massachusetts merkezli bu \u015firket biyolojik t\u0131p ilerlemesinin dalgas\u0131na binmek i\u00e7in benzersiz bir f\u0131rsat sunuyor. RGEN'in neden dikkatinizi hak etti\u011fini ve potansiyel b\u00fcy\u00fcme i\u00e7in kendinizi nas\u0131l konumland\u0131rabilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u00fcy\u00fcyen biyoprocessing devriminden faydalanmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Repligen Corporation, ya\u015fam bilimleri inovasyonunun \u00f6n saflar\u0131nda yer alarak, yeni nesil tedavilerin geli\u015ftirilmesini destekliyor. K\u00fcresel biyoprocessing pazar\u0131 2030 y\u0131l\u0131na kadar 25 milyar dolardan 50 milyar dolar\u0131n \u00fczerine \u00e7\u0131karken, Massachusetts merkezli bu \u015firket biyolojik t\u0131p ilerlemesinin dalgas\u0131na binmek i\u00e7in benzersiz bir f\u0131rsat sunuyor. RGEN'in neden dikkatinizi hak etti\u011fini ve potansiyel b\u00fcy\u00fcme i\u00e7in kendinizi nas\u0131l konumland\u0131rabilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Repligen Hisse Analizi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>28 A\u011fustos 2025 itibar\u0131yla, Repligen Corporation (RGEN) NASDAQ borsas\u0131nda <strong>118,88 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Bu fiyat, hissenin 52 haftal\u0131k aral\u0131\u011f\u0131 olan 102,97 $ ile 182,52 $ aras\u0131nda yakla\u015f\u0131k %35 y\u0131ll\u0131k zirvesinin alt\u0131nda olmas\u0131 nedeniyle ilgi \u00e7ekici bir giri\u015f noktas\u0131 sunuyor.<\/p> <p><strong>Takviminize Not Edin: 11 Kas\u0131m 2025<\/strong> - bir sonraki b\u00fcy\u00fck kataliz\u00f6r\u00fcn\u00fcz bu tarih. Repligen \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve ge\u00e7mi\u015fte bu t\u00fcr olaylar\u0131n hisse \u00fczerinde \u00f6nemli etkileri olmu\u015ftur. 29 Temmuz 2025 kazan\u00e7 a\u00e7\u0131klamas\u0131na bak\u0131ld\u0131\u011f\u0131nda, hisse kar\u0131\u015f\u0131k tepkiler g\u00f6stermi\u015f olsa da temel g\u00f6stergeler sa\u011flamd\u0131.<\/p> <p><strong>Kazan\u00e7 Etkisi Analizi:<\/strong><\/p> <ul> <li>29 Temmuz 2025: 0,37 $ EPS bildirdi (0,40 $ tahminini ka\u00e7\u0131rd\u0131) ancak 182,37 milyon $ gelir beklentisini a\u015ft\u0131<\/li> <li>Hisse tepkisi: \u0130lk etapta %5 g\u00fcnl\u00fck dalgalanmalarla oynak<\/li> <li>Sonraki hafta: 115-125 $ aral\u0131\u011f\u0131nda konsolidasyon paterni olu\u015ftu<\/li> <li>\u00d6nceki \u00e7eyrek paterni: G\u00fc\u00e7l\u00fc gelir art\u0131\u015f\u0131 genellikle zamanla \u00f6d\u00fcllendirildi<\/li> <\/ul> <p>Bu patern, k\u0131sa vadeli tepkilerin \u00f6ng\u00f6r\u00fclemez olabilece\u011fini ancak Repligen'in tutarl\u0131 gelir art\u0131\u015f\u0131n\u0131n (%14,8 Y\u0131ll\u0131k %2. \u00e7eyrekte) sonunda piyasa taraf\u0131ndan tan\u0131nd\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>  [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2> <p>Repligen hissesi son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a hareketli bir yolculu\u011fa \u00e7\u0131kard\u0131:<\/p> <ul> <li><strong>\u015eubat-Mart 2025:<\/strong> Biyoteknoloji hissiyat\u0131n\u0131n iyile\u015fmesiyle 135-145 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc<\/li> <li><strong>Nisan D\u00fczeltmesi:<\/strong> Daha geni\u015f piyasa oynakl\u0131\u011f\u0131 nedeniyle 112 $ seviyelerine d\u00fc\u015ft\u00fc<\/li> <li><strong>May\u0131s Toparlanmas\u0131:<\/strong> %10 gelir art\u0131\u015f\u0131 g\u00f6steren g\u00fc\u00e7l\u00fc 1. \u00e7eyrek kazan\u00e7lar\u0131yla 125 $ seviyesine s\u0131\u00e7rad\u0131<\/li> <li><strong>Haziran \u0130stikrar\u0131:<\/strong> Kurumsal yat\u0131r\u0131mc\u0131lar\u0131n al\u0131mlar\u0131yla 118-128 $ aral\u0131\u011f\u0131nda konsolide oldu<\/li> <li><strong>Temmuz Oynakl\u0131\u011f\u0131:<\/strong> Sa\u011flam temellere ra\u011fmen 111-124 $ aras\u0131nda kazan\u00e7 kaynakl\u0131 dalgalanmalar ya\u015fand\u0131<\/li> <li><strong>G\u00fcncel A\u011fustos:<\/strong> 118-125 $ destek b\u00f6lgesinde istikrar sa\u011flan\u0131yor<\/li> <\/ul> <p><strong>52 haftal\u0131k zirvelerden %34 d\u00fc\u015f\u00fc\u015f<\/strong> endi\u015fe verici g\u00f6r\u00fcnebilir ancak bu, \u015firket \u00f6zelinden ziyade sekt\u00f6r genelindeki biyoteknoloji bask\u0131s\u0131n\u0131 yans\u0131t\u0131yor. Bu arada, i\u00e7eriden ve kurumsal yat\u0131r\u0131mc\u0131lar al\u0131m yapmaya devam ediyor - Y\u00f6netim Kurulu \u00dcyesi Martin Madaus A\u011fustos ba\u015f\u0131nda 1.800 hisseyi 112,13 $'dan sat\u0131n ald\u0131, Ameriprise Financial ve Northern Trust ise pozisyonlar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131rd\u0131.<\/p>  <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2> <p>Mevcut analist konsens\u00fcs\u00fc ve sekt\u00f6r trendlerine dayanarak, gelecekte neler olabilece\u011fi \u015f\u00f6yle:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu Hedefi:<\/strong> 165-175 $ (mevcut seviyelerden %38-47 y\u00fckseli\u015f)<br> Analistler \"Orta Al\" derecelendirmelerini koruyor ve ortalama fiyat hedefleri <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/RGEN\/forecast\/\">MarketBeat analizine<\/a> g\u00f6re yakla\u015f\u0131k 169,45 $ civar\u0131nda. \u015eirketin 2025 mali y\u0131l\u0131 EPS rehberli\u011fi 1,65-1,72 $ aral\u0131\u011f\u0131nda bu iyimserli\u011fi destekliyor.<\/li> <li><strong>2026 G\u00f6r\u00fcn\u00fcm\u00fc:<\/strong> 185-210 $<br> Biyoprocessing pazar\u0131 29 milyar dolar\u0131n \u00fczerine \u00e7\u0131karken ve Repligen'in stratejik ortakl\u0131klar\u0131 (\u00f6rne\u011fin Temmuz 2025 Novasign i\u015fbirli\u011fi) meyvelerini verirken, \u00e7ift haneli b\u00fcy\u00fcmenin devam\u0131 m\u00fcmk\u00fcn g\u00f6r\u00fcn\u00fcyor.<\/li> <li><strong>2028 Projeksiyonu:<\/strong> 240-280 $<br> 2028 y\u0131l\u0131na kadar k\u00fcresel biyoprocessing pazar\u0131 48-53 milyar dolar seviyesine ula\u015facak. Repligen pazar konumunu korursa, bu hisse de\u011ferinde \u00f6nemli art\u0131\u015f anlam\u0131na gelebilir.<\/li> <li><strong>2030 Vizyonu:<\/strong> 300-350 $+<br> Biyolojik tedaviler ana ak\u0131m haline geldik\u00e7e ve \u00fcretim karma\u015f\u0131kl\u0131\u011f\u0131 artt\u0131k\u00e7a, Repligen'in \u00f6zel ekipman ve sarf malzemelerine olan talep artacak ve uzun vadeli hikaye \u00e7ekici kalacak.<\/li> <\/ul> <p><strong>Sonu\u00e7: AL<\/strong> - Mevcut seviyeler sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in cazip risk-getiri sunuyor.<\/p>  <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <p><strong>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/strong><\/p> <ul> <li><strong>Y\u00fcksek oynakl\u0131k:<\/strong> 0,95 beta de\u011feri y\u0131ll\u0131k %30-40 dalgalanmalar\u0131n normal oldu\u011funu g\u00f6steriyor<\/li> <li><strong>Sekt\u00f6r duyarl\u0131l\u0131\u011f\u0131:<\/strong> Biyoteknoloji finansman\u0131ndaki d\u00fc\u015f\u00fc\u015fler (\u00f6rne\u011fin 2025 1. \u00e7eyrekteki \u00f6nemli azalma) ekipman al\u0131mlar\u0131n\u0131 do\u011frudan etkiliyor<\/li> <li><strong>Co\u011frafi yo\u011funla\u015fma:<\/strong> \u00c7in'deki zay\u0131fl\u0131k (1. \u00e7eyrek gelirinin sadece %2'si) ve olas\u0131 Avrupa tarifeleri etkileri<\/li> <li><strong>Uygulama riski:<\/strong> Son kazan\u00e7 ka\u00e7\u0131rmas\u0131 (0,37 $ vs 0,40 $ beklenti) marj bask\u0131s\u0131n\u0131 g\u00f6steriyor<\/li> <\/ul> <p><strong>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/strong><\/p> <ul> <li><strong>G\u00fc\u00e7l\u00fc temeller:<\/strong> 2. \u00e7eyrekte %14,8 gelir art\u0131\u015f\u0131, %17 organik COVID d\u0131\u015f\u0131 b\u00fcy\u00fcme<\/li> <li><strong>Sipari\u015f ivmesi:<\/strong> Y\u0131ll\u0131k %20+ sipari\u015f b\u00fcy\u00fcmesi, sekizinci \u00e7eyrek \u00fcst \u00fcste sipari\u015flerin geliri a\u015fmas\u0131<\/li> <li><strong>Sekt\u00f6r r\u00fczgarlar\u0131:<\/strong> Biyoprocessing pazar\u0131 2025'te %15,7 CAGR ile 29 milyar dolar\u0131n \u00fczerine \u00e7\u0131k\u0131yor<\/li> <li><strong>Stratejik konumlanma:<\/strong> Novasign ile biyoprocessing dijitalle\u015fmesi ortakl\u0131\u011f\u0131 rekabet avantaj\u0131n\u0131 g\u00fc\u00e7lendiriyor<\/li> <li><strong>Kurumsal g\u00fcven:<\/strong> Son i\u00e7eriden al\u0131mlar ve kurumsal birikimler ak\u0131ll\u0131 para ilgisini g\u00f6steriyor<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> - Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5'inden fazlas\u0131n\u0131 ba\u015flang\u0131\u00e7ta RGEN'e ay\u0131rmay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong> - T\u00fcm\u00fcn\u00fc bir kerede almak yerine par\u00e7a par\u00e7a almay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong> - Potansiyel f\u0131rsatlar i\u00e7in 115 $ alt\u0131, k\u0131r\u0131lma onay\u0131 i\u00e7in 130 $ \u00fcst\u00fc<\/li> <li><strong>Kas\u0131m kazan\u00e7lar\u0131n\u0131 takip edin<\/strong> - Konsolidasyonu k\u0131rabilecek kataliz\u00f6r olabilir<\/li> <li><strong>Esprili ger\u00e7eklik kontrol\u00fc<\/strong>: \"Biyoteknoloji hisseleriyle i\u015flem yapmak, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir - b\u00fcy\u00fcleyici potansiyel ama deneyler planland\u0131\u011f\u0131 gibi gitmedi\u011finde duygusal dalgalanmalara haz\u0131rl\u0131kl\u0131 olun!\"<\/li> <\/ol>  <h2>\u2705 Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table border=\"1\" cellpadding=\"5\" cellspacing=\"0\"> <thead> <tr> <th>Ad\u0131m<\/th> <th>\u0130\u015flem<\/th> <th>Neden \u00d6nemli<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Bir i\u015flem platformu se\u00e7in<\/td> <td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sundu\u011fundan emin olun<\/td> <\/tr> <tr> <td>2<\/td> <td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td> <td>Genellikle kimlik ve adres kan\u0131t\u0131 gerektirir<\/td> <\/tr> <tr> <td>3<\/td> <td>Fon yat\u0131r\u0131n<\/td> <td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td> <\/tr> <tr> <td>4<\/td> <td>\"RGEN\" aramas\u0131 yap\u0131n<\/td> <td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td> <\/tr> <tr> <td>5<\/td> <td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td> <td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri \u00f6nerilir<\/td> <\/tr> <tr> <td>6<\/td> <td>Sipari\u015f detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td> <td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td> <\/tr> <tr> <td>7<\/td> <td>Sat\u0131n alma i\u015flemini ger\u00e7ekle\u015ftirin<\/td> <td>Sipari\u015fi onaylay\u0131n ve y\u00fcr\u00fctmeyi takip edin<\/td> <\/tr> <tr> <td>8<\/td> <td>Takip kurulumunu yap\u0131n<\/td> <td>Fiyat uyar\u0131lar\u0131 olu\u015fturun ve performans\u0131 izleyin<\/td> <\/tr> <tr> <td>9<\/td> <td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td> <td>K\u00e2r hedefleri ve zarar durdurma seviyelerini belirleyin<\/td> <\/tr> <tr> <td>10<\/td> <td>\u0130\u015flemi belgeleyin<\/td> <td>Vergi ama\u00e7lar\u0131 i\u00e7in kay\u0131t tutun<\/td> <\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Mant\u0131kl\u0131?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, Repligen gibi \u015firketlerde pozisyon olu\u015fturmak i\u00e7in m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar:<\/p> <p><strong>Sadece 5 $ minimum depozito<\/strong> ile stratejileri d\u00fc\u015f\u00fck riskle test ederken piyasalar\u0131 \u00f6\u011frenebilirsiniz. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> sayesinde kay\u0131t olduktan hemen sonra i\u015flem yapmaya ba\u015flayabilirsiniz - sadece herhangi bir resmi kimlik y\u00fckleyin ve haz\u0131rs\u0131n\u0131z.<\/p> <p><strong>100'den fazla para \u00e7ekme y\u00f6ntemi<\/strong> aras\u0131nda kripto paralar, e-c\u00fczdanlar ve geleneksel banka se\u00e7enekleri bulunur; b\u00f6ylece yat\u0131r\u0131m getirilerinizi y\u00f6netmede esneklik sa\u011flars\u0131n\u0131z. Bu eri\u015filebilirlik, Pocket Option'u Repligen gibi umut vadeden \u015firketlerde pozisyonlar\u0131n\u0131 kademeli olarak olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6zellikle cazip k\u0131lar.<\/p>  <h2>\ud83c\udf0d 2025'te Repligen: Biyoprocessing'in \u0130novasyon Motoru<\/h2> <p>Repligen Corporation, k\u00fcresel ya\u015fam bilimleri devriminin kritik bir destekleyicisidir. \u015eirket, biyolojik ila\u00e7 \u00fcretimi i\u00e7in gerekli teknolojiler ve \u00e7\u00f6z\u00fcmler sunarak, d\u00fcnya \u00e7ap\u0131nda ila\u00e7 firmalar\u0131, biyoteknoloji \u015firketleri ve ara\u015ft\u0131rma kurumlar\u0131na hizmet vermektedir. \u00dcr\u00fcn portf\u00f6y\u00fc; filtrasyon sistemleri, kromatografi ekipmanlar\u0131, proses analiti\u011fi ve protein \u00fcretim teknolojilerini kapsar - biyolojik ila\u00e7lar\u0131n geli\u015ftirilmesi ve \u00fcretilmesi i\u00e7in temel bile\u015fenlerdir.<\/p> <p>Repligen'i 2025'te \u00f6zellikle ilgin\u00e7 k\u0131lan, dijitalle\u015fme ve inovasyona y\u00f6nelik stratejik d\u00f6n\u00fc\u015f\u00fcm\u00fcd\u00fcr. Temmuz 2025'te Novasign ile yap\u0131lan ortakl\u0131k, biyoprocessing dijitalle\u015fmesini ilerletmeye odaklanarak \u015firketi geleneksel biyoproduksiyon ile ileri teknoloji entegrasyonunun kesi\u015fim noktas\u0131na yerle\u015ftiriyor.<\/p> <p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek:<\/strong> Repligen'in ekipman ve sarf malzemeleri, piyasadaki <strong>FDA onayl\u0131 biyolojik ila\u00e7lar\u0131n yakla\u015f\u0131k %65'inin<\/strong> \u00fcretiminde kullan\u0131lm\u0131\u015f olup, modern t\u0131p \u00fcretiminin g\u00f6r\u00fcnmez ama vazge\u00e7ilmez omurgas\u0131n\u0131 olu\u015fturuyor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Repligen Hisse Analizi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>28 A\u011fustos 2025 itibar\u0131yla, Repligen Corporation (RGEN) NASDAQ borsas\u0131nda <strong>118,88 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Bu fiyat, hissenin 52 haftal\u0131k aral\u0131\u011f\u0131 olan 102,97 $ ile 182,52 $ aras\u0131nda yakla\u015f\u0131k %35 y\u0131ll\u0131k zirvesinin alt\u0131nda olmas\u0131 nedeniyle ilgi \u00e7ekici bir giri\u015f noktas\u0131 sunuyor.<\/p>\n<p><strong>Takviminize Not Edin: 11 Kas\u0131m 2025<\/strong> &#8211; bir sonraki b\u00fcy\u00fck kataliz\u00f6r\u00fcn\u00fcz bu tarih. Repligen \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve ge\u00e7mi\u015fte bu t\u00fcr olaylar\u0131n hisse \u00fczerinde \u00f6nemli etkileri olmu\u015ftur. 29 Temmuz 2025 kazan\u00e7 a\u00e7\u0131klamas\u0131na bak\u0131ld\u0131\u011f\u0131nda, hisse kar\u0131\u015f\u0131k tepkiler g\u00f6stermi\u015f olsa da temel g\u00f6stergeler sa\u011flamd\u0131.<\/p>\n<p><strong>Kazan\u00e7 Etkisi Analizi:<\/strong><\/p>\n<ul>\n<li>29 Temmuz 2025: 0,37 $ EPS bildirdi (0,40 $ tahminini ka\u00e7\u0131rd\u0131) ancak 182,37 milyon $ gelir beklentisini a\u015ft\u0131<\/li>\n<li>Hisse tepkisi: \u0130lk etapta %5 g\u00fcnl\u00fck dalgalanmalarla oynak<\/li>\n<li>Sonraki hafta: 115-125 $ aral\u0131\u011f\u0131nda konsolidasyon paterni olu\u015ftu<\/li>\n<li>\u00d6nceki \u00e7eyrek paterni: G\u00fc\u00e7l\u00fc gelir art\u0131\u015f\u0131 genellikle zamanla \u00f6d\u00fcllendirildi<\/li>\n<\/ul>\n<p>Bu patern, k\u0131sa vadeli tepkilerin \u00f6ng\u00f6r\u00fclemez olabilece\u011fini ancak Repligen&#8217;in tutarl\u0131 gelir art\u0131\u015f\u0131n\u0131n (%14,8 Y\u0131ll\u0131k %2. \u00e7eyrekte) sonunda piyasa taraf\u0131ndan tan\u0131nd\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2>\n<p>Repligen hissesi son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a hareketli bir yolculu\u011fa \u00e7\u0131kard\u0131:<\/p>\n<ul>\n<li><strong>\u015eubat-Mart 2025:<\/strong> Biyoteknoloji hissiyat\u0131n\u0131n iyile\u015fmesiyle 135-145 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc<\/li>\n<li><strong>Nisan D\u00fczeltmesi:<\/strong> Daha geni\u015f piyasa oynakl\u0131\u011f\u0131 nedeniyle 112 $ seviyelerine d\u00fc\u015ft\u00fc<\/li>\n<li><strong>May\u0131s Toparlanmas\u0131:<\/strong> %10 gelir art\u0131\u015f\u0131 g\u00f6steren g\u00fc\u00e7l\u00fc 1. \u00e7eyrek kazan\u00e7lar\u0131yla 125 $ seviyesine s\u0131\u00e7rad\u0131<\/li>\n<li><strong>Haziran \u0130stikrar\u0131:<\/strong> Kurumsal yat\u0131r\u0131mc\u0131lar\u0131n al\u0131mlar\u0131yla 118-128 $ aral\u0131\u011f\u0131nda konsolide oldu<\/li>\n<li><strong>Temmuz Oynakl\u0131\u011f\u0131:<\/strong> Sa\u011flam temellere ra\u011fmen 111-124 $ aras\u0131nda kazan\u00e7 kaynakl\u0131 dalgalanmalar ya\u015fand\u0131<\/li>\n<li><strong>G\u00fcncel A\u011fustos:<\/strong> 118-125 $ destek b\u00f6lgesinde istikrar sa\u011flan\u0131yor<\/li>\n<\/ul>\n<p><strong>52 haftal\u0131k zirvelerden %34 d\u00fc\u015f\u00fc\u015f<\/strong> endi\u015fe verici g\u00f6r\u00fcnebilir ancak bu, \u015firket \u00f6zelinden ziyade sekt\u00f6r genelindeki biyoteknoloji bask\u0131s\u0131n\u0131 yans\u0131t\u0131yor. Bu arada, i\u00e7eriden ve kurumsal yat\u0131r\u0131mc\u0131lar al\u0131m yapmaya devam ediyor &#8211; Y\u00f6netim Kurulu \u00dcyesi Martin Madaus A\u011fustos ba\u015f\u0131nda 1.800 hisseyi 112,13 $&#8217;dan sat\u0131n ald\u0131, Ameriprise Financial ve Northern Trust ise pozisyonlar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131rd\u0131.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2>\n<p>Mevcut analist konsens\u00fcs\u00fc ve sekt\u00f6r trendlerine dayanarak, gelecekte neler olabilece\u011fi \u015f\u00f6yle:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu Hedefi:<\/strong> 165-175 $ (mevcut seviyelerden %38-47 y\u00fckseli\u015f)<br \/> Analistler &#8220;Orta Al&#8221; derecelendirmelerini koruyor ve ortalama fiyat hedefleri <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/RGEN\/forecast\/\">MarketBeat analizine<\/a> g\u00f6re yakla\u015f\u0131k 169,45 $ civar\u0131nda. \u015eirketin 2025 mali y\u0131l\u0131 EPS rehberli\u011fi 1,65-1,72 $ aral\u0131\u011f\u0131nda bu iyimserli\u011fi destekliyor.<\/li>\n<li><strong>2026 G\u00f6r\u00fcn\u00fcm\u00fc:<\/strong> 185-210 $<br \/> Biyoprocessing pazar\u0131 29 milyar dolar\u0131n \u00fczerine \u00e7\u0131karken ve Repligen&#8217;in stratejik ortakl\u0131klar\u0131 (\u00f6rne\u011fin Temmuz 2025 Novasign i\u015fbirli\u011fi) meyvelerini verirken, \u00e7ift haneli b\u00fcy\u00fcmenin devam\u0131 m\u00fcmk\u00fcn g\u00f6r\u00fcn\u00fcyor.<\/li>\n<li><strong>2028 Projeksiyonu:<\/strong> 240-280 $<br \/> 2028 y\u0131l\u0131na kadar k\u00fcresel biyoprocessing pazar\u0131 48-53 milyar dolar seviyesine ula\u015facak. Repligen pazar konumunu korursa, bu hisse de\u011ferinde \u00f6nemli art\u0131\u015f anlam\u0131na gelebilir.<\/li>\n<li><strong>2030 Vizyonu:<\/strong> 300-350 $+<br \/> Biyolojik tedaviler ana ak\u0131m haline geldik\u00e7e ve \u00fcretim karma\u015f\u0131kl\u0131\u011f\u0131 artt\u0131k\u00e7a, Repligen&#8217;in \u00f6zel ekipman ve sarf malzemelerine olan talep artacak ve uzun vadeli hikaye \u00e7ekici kalacak.<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7: AL<\/strong> &#8211; Mevcut seviyeler sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in cazip risk-getiri sunuyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<p><strong>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/strong><\/p>\n<ul>\n<li><strong>Y\u00fcksek oynakl\u0131k:<\/strong> 0,95 beta de\u011feri y\u0131ll\u0131k %30-40 dalgalanmalar\u0131n normal oldu\u011funu g\u00f6steriyor<\/li>\n<li><strong>Sekt\u00f6r duyarl\u0131l\u0131\u011f\u0131:<\/strong> Biyoteknoloji finansman\u0131ndaki d\u00fc\u015f\u00fc\u015fler (\u00f6rne\u011fin 2025 1. \u00e7eyrekteki \u00f6nemli azalma) ekipman al\u0131mlar\u0131n\u0131 do\u011frudan etkiliyor<\/li>\n<li><strong>Co\u011frafi yo\u011funla\u015fma:<\/strong> \u00c7in&#8217;deki zay\u0131fl\u0131k (1. \u00e7eyrek gelirinin sadece %2&#8217;si) ve olas\u0131 Avrupa tarifeleri etkileri<\/li>\n<li><strong>Uygulama riski:<\/strong> Son kazan\u00e7 ka\u00e7\u0131rmas\u0131 (0,37 $ vs 0,40 $ beklenti) marj bask\u0131s\u0131n\u0131 g\u00f6steriyor<\/li>\n<\/ul>\n<p><strong>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/strong><\/p>\n<ul>\n<li><strong>G\u00fc\u00e7l\u00fc temeller:<\/strong> 2. \u00e7eyrekte %14,8 gelir art\u0131\u015f\u0131, %17 organik COVID d\u0131\u015f\u0131 b\u00fcy\u00fcme<\/li>\n<li><strong>Sipari\u015f ivmesi:<\/strong> Y\u0131ll\u0131k %20+ sipari\u015f b\u00fcy\u00fcmesi, sekizinci \u00e7eyrek \u00fcst \u00fcste sipari\u015flerin geliri a\u015fmas\u0131<\/li>\n<li><strong>Sekt\u00f6r r\u00fczgarlar\u0131:<\/strong> Biyoprocessing pazar\u0131 2025&#8217;te %15,7 CAGR ile 29 milyar dolar\u0131n \u00fczerine \u00e7\u0131k\u0131yor<\/li>\n<li><strong>Stratejik konumlanma:<\/strong> Novasign ile biyoprocessing dijitalle\u015fmesi ortakl\u0131\u011f\u0131 rekabet avantaj\u0131n\u0131 g\u00fc\u00e7lendiriyor<\/li>\n<li><strong>Kurumsal g\u00fcven:<\/strong> Son i\u00e7eriden al\u0131mlar ve kurumsal birikimler ak\u0131ll\u0131 para ilgisini g\u00f6steriyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> &#8211; Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5&#8217;inden fazlas\u0131n\u0131 ba\u015flang\u0131\u00e7ta RGEN&#8217;e ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong> &#8211; T\u00fcm\u00fcn\u00fc bir kerede almak yerine par\u00e7a par\u00e7a almay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong> &#8211; Potansiyel f\u0131rsatlar i\u00e7in 115 $ alt\u0131, k\u0131r\u0131lma onay\u0131 i\u00e7in 130 $ \u00fcst\u00fc<\/li>\n<li><strong>Kas\u0131m kazan\u00e7lar\u0131n\u0131 takip edin<\/strong> &#8211; Konsolidasyonu k\u0131rabilecek kataliz\u00f6r olabilir<\/li>\n<li><strong>Esprili ger\u00e7eklik kontrol\u00fc<\/strong>: &#8220;Biyoteknoloji hisseleriyle i\u015flem yapmak, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir &#8211; b\u00fcy\u00fcleyici potansiyel ama deneyler planland\u0131\u011f\u0131 gibi gitmedi\u011finde duygusal dalgalanmalara haz\u0131rl\u0131kl\u0131 olun!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table border=\"1\" cellpadding=\"5\" cellspacing=\"0\">\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir i\u015flem platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Genellikle kimlik ve adres kan\u0131t\u0131 gerektirir<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;RGEN&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Sadece \u015firket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri \u00f6nerilir<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Sipari\u015f detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td>\n<td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Sat\u0131n alma i\u015flemini ger\u00e7ekle\u015ftirin<\/td>\n<td>Sipari\u015fi onaylay\u0131n ve y\u00fcr\u00fctmeyi takip edin<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Takip kurulumunu yap\u0131n<\/td>\n<td>Fiyat uyar\u0131lar\u0131 olu\u015fturun ve performans\u0131 izleyin<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td>\n<td>K\u00e2r hedefleri ve zarar durdurma seviyelerini belirleyin<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u0130\u015flemi belgeleyin<\/td>\n<td>Vergi ama\u00e7lar\u0131 i\u00e7in kay\u0131t tutun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Mant\u0131kl\u0131?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, Repligen gibi \u015firketlerde pozisyon olu\u015fturmak i\u00e7in m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar:<\/p>\n<p><strong>Sadece 5 $ minimum depozito<\/strong> ile stratejileri d\u00fc\u015f\u00fck riskle test ederken piyasalar\u0131 \u00f6\u011frenebilirsiniz. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> sayesinde kay\u0131t olduktan hemen sonra i\u015flem yapmaya ba\u015flayabilirsiniz &#8211; sadece herhangi bir resmi kimlik y\u00fckleyin ve haz\u0131rs\u0131n\u0131z.<\/p>\n<p><strong>100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/strong> aras\u0131nda kripto paralar, e-c\u00fczdanlar ve geleneksel banka se\u00e7enekleri bulunur; b\u00f6ylece yat\u0131r\u0131m getirilerinizi y\u00f6netmede esneklik sa\u011flars\u0131n\u0131z. Bu eri\u015filebilirlik, Pocket Option&#8217;u Repligen gibi umut vadeden \u015firketlerde pozisyonlar\u0131n\u0131 kademeli olarak olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in \u00f6zellikle cazip k\u0131lar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Repligen: Biyoprocessing&#8217;in \u0130novasyon Motoru<\/h2>\n<p>Repligen Corporation, k\u00fcresel ya\u015fam bilimleri devriminin kritik bir destekleyicisidir. \u015eirket, biyolojik ila\u00e7 \u00fcretimi i\u00e7in gerekli teknolojiler ve \u00e7\u00f6z\u00fcmler sunarak, d\u00fcnya \u00e7ap\u0131nda ila\u00e7 firmalar\u0131, biyoteknoloji \u015firketleri ve ara\u015ft\u0131rma kurumlar\u0131na hizmet vermektedir. \u00dcr\u00fcn portf\u00f6y\u00fc; filtrasyon sistemleri, kromatografi ekipmanlar\u0131, proses analiti\u011fi ve protein \u00fcretim teknolojilerini kapsar &#8211; biyolojik ila\u00e7lar\u0131n geli\u015ftirilmesi ve \u00fcretilmesi i\u00e7in temel bile\u015fenlerdir.<\/p>\n<p>Repligen&#8217;i 2025&#8217;te \u00f6zellikle ilgin\u00e7 k\u0131lan, dijitalle\u015fme ve inovasyona y\u00f6nelik stratejik d\u00f6n\u00fc\u015f\u00fcm\u00fcd\u00fcr. Temmuz 2025&#8217;te Novasign ile yap\u0131lan ortakl\u0131k, biyoprocessing dijitalle\u015fmesini ilerletmeye odaklanarak \u015firketi geleneksel biyoproduksiyon ile ileri teknoloji entegrasyonunun kesi\u015fim noktas\u0131na yerle\u015ftiriyor.<\/p>\n<p><strong>2025 \u0130\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek:<\/strong> Repligen&#8217;in ekipman ve sarf malzemeleri, piyasadaki <strong>FDA onayl\u0131 biyolojik ila\u00e7lar\u0131n yakla\u015f\u0131k %65&#8217;inin<\/strong> \u00fcretiminde kullan\u0131lm\u0131\u015f olup, modern t\u0131p \u00fcretiminin g\u00f6r\u00fcnmez ama vazge\u00e7ilmez omurgas\u0131n\u0131 olu\u015fturuyor.<\/p>\n"},"faq":[{"question":"Repligen hisseleri nereden al\u0131nabilir?","answer":"Repligen hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve i\u015flem platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Repligen hissesi i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ti\u011finiz platforma ba\u011fl\u0131d\u0131r, ancak Pocket Option gibi platformlarda sadece 5 $ ile ba\u015flayabilirsiniz."},{"question":"Repligen hissesi ne kadar risklidir?","answer":"Repligen hissesi y\u00fcksek oynakl\u0131\u011fa sahiptir (beta 0,95) ve y\u0131ll\u0131k %30-40 dalgalanmalar normaldir, bu nedenle risk tolerans\u0131n\u0131za uygun yat\u0131r\u0131m yapmal\u0131s\u0131n\u0131z."},{"question":"Repligen hissesi i\u00e7in gelecekteki fiyat tahmini nedir?","answer":"Analistlerin tahminlerine g\u00f6re 2025 sonunda 165-175 $ aral\u0131\u011f\u0131nda, 2030 y\u0131l\u0131nda ise 300-350 $ ve \u00fczeri seviyelerde olabilir."},{"question":"Yeni ba\u015flayan biri Repligen hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, fiyat uyar\u0131lar\u0131 kurun ve \u00f6nemli kazan\u00e7 a\u00e7\u0131klamalar\u0131n\u0131 takip edin."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Repligen hisseleri nereden al\u0131nabilir?","answer":"Repligen hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve i\u015flem platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Repligen hissesi i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ti\u011finiz platforma ba\u011fl\u0131d\u0131r, ancak Pocket Option gibi platformlarda sadece 5 $ ile ba\u015flayabilirsiniz."},{"question":"Repligen hissesi ne kadar risklidir?","answer":"Repligen hissesi y\u00fcksek oynakl\u0131\u011fa sahiptir (beta 0,95) ve y\u0131ll\u0131k %30-40 dalgalanmalar normaldir, bu nedenle risk tolerans\u0131n\u0131za uygun yat\u0131r\u0131m yapmal\u0131s\u0131n\u0131z."},{"question":"Repligen hissesi i\u00e7in gelecekteki fiyat tahmini nedir?","answer":"Analistlerin tahminlerine g\u00f6re 2025 sonunda 165-175 $ aral\u0131\u011f\u0131nda, 2030 y\u0131l\u0131nda ise 300-350 $ ve \u00fczeri seviyelerde olabilir."},{"question":"Yeni ba\u015flayan biri Repligen hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, fiyat uyar\u0131lar\u0131 kurun ve \u00f6nemli kazan\u00e7 a\u00e7\u0131klamalar\u0131n\u0131 takip edin."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Repligen Corporation (RGEN) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Repligen Corporation (RGEN) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T10:36:46+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Repligen Corporation (RGEN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-28T10:36:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/\",\"name\":\"Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Repligen Corporation (RGEN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"datePublished\":\"2025-08-28T10:36:46+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Repligen Corporation (RGEN) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Repligen Corporation (RGEN) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/","og_locale":"tr_TR","og_type":"article","og_title":"Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Repligen Corporation (RGEN) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T10:36:46+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Repligen Corporation (RGEN) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-28T10:36:46+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/","name":"Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Repligen Corporation (RGEN) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","datePublished":"2025-08-28T10:36:46+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-repligen-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Repligen Corporation (RGEN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Repligen Corporation (RGEN) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":354067,"slug":"how-to-buy-repligen-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Repligen Corporation (RGEN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Repligen Corporation (RGEN)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-repligen-corporation\/"},"pt_AA":{"locale":"pt_AA","id":354068,"slug":"how-to-buy-repligen-corporation","post_title":"Como comprar a\u00e7\u00f5es da Repligen Corporation (RGEN) - Investimento em a\u00e7\u00f5es da Repligen Corporation (RGEN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-repligen-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=354066"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354066\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334018"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=354066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=354066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=354066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}